In vitro activity of sertaconazole against dermatophyte isolates with reduced fluconazole susceptibility

Chemotherapy

Volumn 49, Issue 5, 2003, Pages 248-251

  Carrillo Munoz A J ^a   Fernandez Torres B ^b   Cardenes D C ^b   Guarro, J ^b  

^a Associacio Catalana d'Intelligencia Artificial   (Spain)

^b UNIVERSITAT ROVIRA I VIRGILI   (Spain)

Author keywords

Dermatophytes; Fluconazole; Sertaconazole

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; IMIDAZOLE DERIVATIVE; SERTACONAZOLE; THIOPHENE DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; ARTHRODERMA; ARTICLE; COMPARATIVE STUDY; CROSS RESISTANCE; DERMATOPHYTE; DRUG EFFECT; DRUG SENSITIVITY; EPIDERMOPHYTON FLOCCOSUM; FUNGUS; FUNGUS ISOLATION; INCUBATION TIME; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MICROSPORUM; MICROSPORUM AUDOUINII; MICROSPORUM CANIS; MICROSPORUM FERRUGINEUM; MICROSPORUM GYPSEUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; ONYCHOMYCOSIS; PRIORITY JOURNAL; TEMPERATURE; TINEA CAPITIS; TRICHOPHYTON; TRICHOPHYTON MENTAGROPHYTES; TRICHOPHYTON RUBRUM; TRICHOPHYTON SCHOENLEINI; TRICHOPHYTON TONSURANS; TRICHOPHYTON VERRUCOSUM; TRICHOPHYTON VIOLACEUM;

ANTIFUNGAL AGENTS; ARTHRODERMATACEAE; DRUG RESISTANCE, FUNGAL; FLUCONAZOLE; IMIDAZOLES; MICROBIAL SENSITIVITY TESTS; ONYCHOMYCOSIS; THIOPHENES; TINEA CAPITIS;

EID: 0141839800     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072449     Document Type: Article

References (32)

1. Berger AR: Common superficial fungal infections in patients with AIDS. Clin Infect Dis 1996;22:128-132.
2. Macura A: Dermatophytes, pathogens or saprophytes. Int J Dermatol 1995;34:529-530.
3. Palacín C, Tarragó C, Agut J, Guglietta A: In vitro activity of sertaconazole, fluconazole, ketoconazole, fenticonazole, clotrimazole and itraconazole against pathogenic vaginal yeast isolates. Methods Find Exp Clin Pharmacol 2001;23:61-64.
4. Agut J, Tarrida N, Sacristán A, Ortiz JA: Anti-inflammatory activity of topically applied sertaconazole nitrate. Methods Find Exp Clin Pharmacol 1996;18:233-234.
5. Ramos G, Cuenca-Estrella M, Monzón A, Rodríguez-Tudela JL: In vitro comparative activity of UR-9825, itraconazole and fluconazole against clinical isolates of Candida spp. J Antimicrob Chemother 1999;44:283-286.
6. Ray MC, Gately LE: Dermatology manifestations of HIV infection in AIDS. Infect Dis Clin North Am 1994;94:583-605.
7. Gupta AK: Onychomycoses in the elderly. Drugs Aging 2000;16:397-407.
8. Gupta AK, Summerbell RC: Tinea capitis. Med Mycol 2000;38:255-287.
9. Agut J, Palacín C, Sacristán A, Ortiz JA: Inhibition of ergosterol synthesis by sertaconazole in Candida albicans. Arzneimittelforschung 1992;42:718-720.
10. Agut J, Palacín C, Salgado J, Casas E, Sacristán A, Ortiz JA: Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity. Arzneimittelforschung 1992;42:721-724.
11. Carrillo-Muñoz AJ, Torres JM: In vitro antifungal activity of sertaconazole, econazole and bifonazole against Candida spp. J Antimicrob Chemother 1995;36:713-726.
12. Drouhet E, Dupont B: In vitro antifungal activity of sertaconazole. Arzneimittelforschung 1992;42:705-710.
13. Palacín C, Sacristán A, Ortiz JA: In vitro activity of sertaconazole. Arzneimittelforschung 1992;42:699-705.
14. Prats G, Mirelis B, Palacín C, Casas E, Sacristán A, Ortiz JA: Actividad antibacteriana in vitro de sertaconazol. Rev Esp Quimioter 1995;8:325-326.
15. Carrillo-Muñoz AJ, Tur-Tur C, Torres J: In vitro activity of sertaconazole, bifonazole, ketoconazole and miconazole against yeasts of the Candida genus. J Antimicrob Chemother 1996;37:815-819.
16. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi: Proposed standard. NCCLS document M38-P. Wayne, National Committee for Laboratory Standards, 1998.
17. Fernández-Torres B, Vázquez-Veiga H, Llovo X, Pereiro M Jr, Guarro J: In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy 2000;46:390-394.
18. Fernández-Torres B, Carrillo-Muñoz AJ, Martín E, del Palacio A, Moore M, Valverde A, Serrano M, Guarro J: In vitro activities of 10 antifungal drugs against 508 dermatophyte isolates. Antimicrob Agents Chemother 2001;45:2524-2528.
19. Fernández-Torres B, Cabañes FJ, Abarca L, Carrillo-Muñoz AJ, Inza I, Guarro J: Collaborative evaluation of optimal antifungal susceptibility testing conditions for dermatophytes. J Clin Microbiol 2002;40:3999-4003.
20. Brega EF, Gonzalez G, Fothergill AW, Sutton DA, Rinaldi MG: An in vitro evaluation of the new triazole antifungal agents against clinical isolates of dermatophytes in comparison with terbinafine, itraconazole, and fluconazole (abstract J205). Abstracts of the 40th Intersciencie Conference on Antimicrobial Agents and Chemotherapy. Washington, American Society for Microbiology, 2000, p 354.
21. Butty P, Lebecq JC, Mallié M, Bastide JM: Evaluation of the susceptibility of dermatophytes to antifungal drugs: A new technique. J Med Vet Mycol 1995;33:403-409.
22. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA: Antifungal susceptibility testing of dermatophytes: Establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000;38:341-344.
23. Mock M, Monod M, Baudruz-Rosselet F, Panizzon RG: Tinea capitis dermatophytes: Susceptibility to antifungal drugs tested in vitro and in vivo. Dermatology 1998;197:361-367.
24. Norris HA, Elewski BE, Ghannoum MA: Optimal growth conditions for the determination of the antifungal susceptibility of three species of dermatophytes with the use of a microdilution method. J Am Acad Dermatol 1999;40:S9-S13.
25. Wildfeuer A, Seidl HP, Paule I, Haberreiter A: In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 1998;41:309-319.
26. Gehrt A, Peter J, Pizzo PA, Walsh TJ: Effect of increasing inoculum sizes of pathogenic filamentous fungi on MICs of antifungal agents by broth microdilution method. J Clin Microbiol 1995;33:1302-1307.
27. Meletiadis J, Meis JF, Mouton JW, Donnelly JP, Verweij PE: Comparison of NCCLS and 3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) methods of in vitro susceptibility testing of filamentous fungi and development of a new simplified method. J Clin Microbiol 2000;38:2949-2954.
28. Carrillo-Muñoz AJ, Tur-Tur C: Comparative study of antifungal activity of sertaconazole, terbinafine and bifonazole against clinical isolates of Candida spp., Cryptococcus neoformans and dermatophytes. Chemotherapy 1997;43:387-392.
29. Bennett JE: Antifungal therapy; in Bennett JE, Grant S (eds): Fluconazole: An Overview. Langhorne, Adis International, 1990, pp 7-25.
30. Palacín C, Tarragó C, Sacristán A, Ortiz JA: Antifungal activity of sertaconazole in the cutaneous retention time test. J Mycol Med 1995;5:35-39.
31. Grau MT, Romero A, Sacristán A, Ortiz JA: Dermal tolerance and phototoxicity studies of sertaconazole. Arzneimittelforschung 1992;42:746-747.
32. Torres J, Márquez M, Camps F: Sertaconazole in the treament of mycoses: From dermatology to gynecology. Int J Gynaecol Obstet 2001;71(suppl 1):S3-S20.